21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Molecular allergen profiling in horses by microarray reveals Fag e 2 from buckwheat as a frequent sensitizer

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Companion animals are also affected by IgE‐mediated allergies, but the eliciting molecules are largely unknown. We aimed at refining an allergen microarray to explore sensitization in horses and compare it to the human IgE reactivity profiles.

          Methods

          Custom‐designed allergen microarray was produced on the basis of the Immuno CAP ISAC technology containing 131 allergens. Sera from 51 horses derived from Europe or Japan were tested for specific IgE reactivity. The included horse patients were diagnosed for eczema due to insect bite hypersensitivity, chronic coughing, recurrent airway obstruction and urticaria or were clinically asymptomatic.

          Results

          Horses showed individual IgE‐binding patterns irrespective of their health status, indicating sensitization. In contrast to European and Japanese human sensitization patterns, frequently recognized allergens were Aln g 1 from alder and Cyn d 1 from Bermuda grass, likely due to specific respiratory exposure around paddocks and near the ground. The most prevalent allergen for 72.5% of the tested horses (37/51) was the 2S‐albumin Fag e 2 from buckwheat, which recently gained importance not only in human but also in horse diet.

          Conclusion

          In line with the One Health concept, covering human health, animal health and environmental health, allergen microarrays provide novel information on the allergen sensitization patterns of the companion animals around us, which may form a basis for allergen‐specific preventive and therapeutic concepts.

          Related collections

          Most cited references75

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Inflammatory Airway Disease of Horses—Revised Consensus Statement

          The purpose of this manuscript is to revise and update the previous consensus statement on inflammatory airway disease (IAD) in horses. Since 2007, a large number of scientific articles have been published on the topic and these new findings have led to a significant evolution of our understanding of IAD.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics

            Molecular-based allergy (MA) diagnostics is an approach used to map the allergen sensitization of a patient at a molecular level, using purified natural or recombinant allergenic molecules (allergen components) instead of allergen extracts. Since its introduction, MA diagnostics has increasingly entered routine care, with currently more than 130 allergenic molecules commercially available for in vitro specific IgE (sIgE) testing. MA diagnostics allows for an increased accuracy in allergy diagnosis and prognosis and plays an important role in three key aspects of allergy diagnosis: (1) resolving genuine versus cross-reactive sensitization in poly-sensitized patients, thereby improving the understanding of triggering allergens; (2) assessing, in selected cases, the risk of severe, systemic versus mild, local reactions in food allergy, thereby reducing unnecessary anxiety for the patient and the need for food challenge testing; and (3) identifying patients and triggering allergens for specific immunotherapy (SIT). Singleplex and multiplex measurement platforms are available for MA diagnostics. The Immuno-Solid phase Allergen Chip (ISAC) is the most comprehensive platform currently available, which involves a biochip technology to measure sIgE antibodies against more than one hundred allergenic molecules in a single assay. As the field of MA diagnostics advances, future work needs to focus on large-scale, population-based studies involving practical applications, elucidation and expansion of additional allergenic molecules, and support for appropriate test interpretation. With the rapidly expanding evidence-base for MA diagnosis, there is a need for allergists to keep abreast of the latest information. The aim of this consensus document is to provide a practical guide for the indications, determination, and interpretation of MA diagnostics for clinicians trained in allergology.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip.

              Allergy diagnosis based on purified allergen molecules provides detailed information regarding the individual sensitization profile of allergic patients, allows monitoring of the development of allergic disease and of the effect of therapies on the immune response to individual allergen molecules. Allergen microarrays contain a large variety of allergen molecules and thus allow the simultaneous detection of allergic patients' antibody reactivity profiles towards each of the allergen molecules with only minute amounts of serum. In this article we summarize recent progress in the field of allergen microarray technology and introduce the MeDALL allergen-chip which has been developed for the specific and sensitive monitoring of IgE and IgG reactivity profiles towards more than 170 allergen molecules in sera collected in European birth cohorts. MeDALL is a European research program in which allergen microarray technology is used for the monitoring of the development of allergic disease in childhood, to draw a geographic map of the recognition of clinically relevant allergens in different populations and to establish reactivity profiles which are associated with and predict certain disease manifestations. We describe technical advances of the MeDALL allergen-chip regarding specificity, sensitivity and its ability to deliver test results which are close to in vivo reactivity. In addition, the usefulness and numerous advantages of allergen microarrays for allergy research, refined allergy diagnosis, monitoring of disease, of the effects of therapies, for improving the prescription of specific immunotherapy and for prevention are discussed. Copyright © 2013 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                erika.jensen-jarolim@meduniwien.ac.at
                Journal
                Allergy
                Allergy
                10.1111/(ISSN)1398-9995
                ALL
                Allergy
                John Wiley and Sons Inc. (Hoboken )
                0105-4538
                1398-9995
                27 February 2018
                July 2018
                : 73
                : 7 ( doiID: 10.1111/all.2018.73.issue-7 )
                : 1436-1446
                Affiliations
                [ 1 ] The interuniversity Messerli Research Institute University of Veterinary Medicine Vienna Medical University Vienna and University Vienna Vienna Austria
                [ 2 ] Institute of Pathophysiology and Allergy Research Center for Pathophysiology, Infectiology and Immunology Medical University of Vienna Vienna Austria
                [ 3 ] Research Group Oncology Equine Clinic University of Veterinary Medicine Vienna Vienna Austria
                [ 4 ] Racehorse Hospital Miho Training Center Japan Racing Association Mikoma Japan
                [ 5 ] Science for Life Laboratory Department of Clinical Science and Education Karolinska Institutet, and Sachs’ Children and Youth Hospital Södersjukhuset Stockholm Sweden
                [ 6 ] Department of Clinical Research and Veterinary Public Health Vetsuisse Faculty University of Bern Bern Switzerland
                [ 7 ] Swiss Institute for Allergy and Asthma Research (SIAF) Davos Switzerland
                [ 8 ] Division of Food Function Research Food Research Institute National Agriculture and Food Research Organization Tsukuba Japan
                [ 9 ] National Institute of Health Sciences Tokyo Japan
                [ 10 ] Laboratory of Comparative Animal Medicine Division of Animal Life Science Tokyo University of Agriculture and Technology Fuchu Japan
                [ 11 ] Laboratory of Veterinary Molecular Pathology and Therapeutics Division of Animal Life Science Tokyo University of Agriculture and Technology Fuchu Japan
                [ 12 ] AllergyCare Allergy Diagnosis and Study Center Vienna Austria
                Author notes
                [*] [* ] Correspondence

                Prof. Erika Jensen‐Jarolim, Institute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology & Immunology, Vienna, Austria.

                Email: erika.jensen-jarolim@ 123456meduniwien.ac.at

                Author information
                http://orcid.org/0000-0002-5488-5022
                http://orcid.org/0000-0003-2077-4479
                http://orcid.org/0000-0002-3837-3422
                http://orcid.org/0000-0001-7969-8445
                http://orcid.org/0000-0003-3722-9135
                http://orcid.org/0000-0001-5520-990X
                http://orcid.org/0000-0002-6240-6730
                http://orcid.org/0000-0002-7933-2547
                http://orcid.org/0000-0003-4250-8243
                http://orcid.org/0000-0001-5944-3365
                http://orcid.org/0000-0003-1284-4350
                http://orcid.org/0000-0003-3339-3923
                http://orcid.org/0000-0002-0139-1766
                http://orcid.org/0000-0003-4310-6430
                http://orcid.org/0000-0002-7906-5047
                http://orcid.org/0000-0003-3189-6842
                http://orcid.org/0000-0003-2089-6011
                http://orcid.org/0000-0003-4019-5765
                Article
                ALL13417
                10.1111/all.13417
                6032949
                29350763
                bbaa6296-868a-45ce-b765-96556f182750
                © 2018 The Authors. Allergy Published by John Wiley & Sons Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 09 January 2018
                Page count
                Figures: 3, Tables: 2, Pages: 11, Words: 7973
                Funding
                Funded by: Austrian Science Fund
                Award ID: MCCA DK W1248‐B30
                Award ID: P26728‐B20
                Award ID: SFB F4605
                Award ID: SFB F4606‐B28
                Categories
                Original Article
                ORIGINAL ARTICLES
                Experimental Allergy and Immunology
                Custom metadata
                2.0
                all13417
                July 2018
                Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.4.3 mode:remove_FC converted:05.07.2018

                Immunology
                allergen,microarray,component‐resolved diagnosis,horse,ige,isac,molecular
                Immunology
                allergen, microarray, component‐resolved diagnosis, horse, ige, isac, molecular

                Comments

                Comment on this article